TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
IMTX

Immatics NV

Healthcare · Biotechnology

8.60$ +0.7% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IMTX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
90.2% 92.3% 93.9% 87.2% 92.5% 88.1% 90.4% 89.6%
64.2% 77.0% 81.5% 76.2% 36.4% 42.8% 34.0% 61.5%
85.6% 88.9% 91.1% 83.1% 88.8% 83.5% 86.8% 83.5%
3.0% 2.0% 1.1% 1.4% 0.3% 1.1% 1.0% 1.2%
0.0% 0.9% 1.3% 0.0% 0.0% 0.0% – –
6.5% 6.0% 5.5% 11.7% 6.5% – – –
1.7% 0.8% 0.4% 0.8% 0.4% 0.3% 0.2% 0.3%
115.0% 130.4% 65.7% 86.2% 50.1% 57.3% 17.4% 13.9%
43.8% 51.6% 30.4% 54.5% 26.1% 30.7% 9.8% 7.6%
– 1.1% 0.7% 1.6% 0.5% 0.5% 0.4% 0.5%
7.8% 3.6% 1.0% 1.7% 3.2% 1.5% 1.5% 0.1%
-17.0% -31.2% 34.3% 13.8% 49.9% 42.7% 82.6% 86.1%
-328.8% -173.7% -174.5% -307.9% -125.1% -118.6% -84.7% -139.8%
102.6% 46.8% 18.9% 36.0% 16.7% 15.8% 15.3% 21.8%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?